GlassScriptPhysician profile
Denise M Casper
NPI 1477504173
$5,702.32
in general payments reported to CMS, 2019-2025
54 companies · $653 in 2025
The $653 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $569 · 2021: $762 · 2022: $860 · 2023: $1,467 · 2024: $887 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,913 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,913.37 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $722.41 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $669.82 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $629.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $428.48 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $338.90 | 2019-2025 | Jardiance |
| Pfizer INC. | $334.59 | 2019-2025 | |
| Astellas Pharma US INC | $328.42 | 2022-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $318.04 | 2020-2025 | Pediarix, Bexsero, Trelegy Ellipta |
| Abbott Laboratories | $152.58 | 2023-2025 | Aveir, Eterna, Freestyle Libre 3 |
| Dexcom, INC. | $150.00 | 2020-2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $122.44 | 2019-2020 | |
| Amgen INC. | $104.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $92.88 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Phathom Pharmaceuticals, INC. | $77.69 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $70.94 | 2020-2023 | Spravato |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.